Lemborexant Treatment of Insomnia Linked to Epilepsy
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Sleep-related focal epilepsy
• Contraception
Locations
United States
North Carolina
Duke University
NOT_YET_RECRUITING
Durham
Other Locations
Canada
Health Sciences Centre
RECRUITING
Winnipeg
Contact Information
Primary
Marcus C Ng, MD, FRCPC
letoile@umanitoba.ca
204-787-2684
Time Frame
Start Date: 2024-10-29
Estimated Completion Date: 2027-04-18
Participants
Target number of participants: 26
Treatments
Placebo_comparator: Placebo First
0mg
Active_comparator: Investigational Product First
10mg qhs
Sponsors
Collaborators: Duke University
Leads: University of Manitoba